These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 917440

  • 21. Experimental models for the study of prostatic adenocarcinoma.
    Smolev JK, Coffey DS, Scott WW.
    J Urol; 1977 Jul; 118(1 Pt 2):216-20. PubMed ID: 875219
    [Abstract] [Full Text] [Related]

  • 22. [Chemotherapy of prostatic cancer].
    Portnoĭ AS.
    Vopr Onkol; 1985 Jul; 31(9):3-12. PubMed ID: 2931901
    [No Abstract] [Full Text] [Related]

  • 23. Endocrine manipulation of the Dunning prostatic adenocarcinoma.
    Shessel FS, Block NL, Stover B, Claflin A, Malinin TI, Politano VA.
    Invest Urol; 1980 May; 17(6):529-33. PubMed ID: 7372443
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of cyclophosphamide alone and scheduled methotrexate-5-fluorouracil combination chemotherapy on transplantable R-3327 prostatic adenocarcinoma in F1 hybrid male rat.
    Smith JB, Ghayad PY, Dhabuwala CB, Drelichman A, Pierce JM.
    Urology; 1987 Aug; 30(2):143-6. PubMed ID: 3617298
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Management of metastatic prostatic cancer.
    Paulson DF.
    Urology; 1985 Feb; 25(2 Suppl):49-52. PubMed ID: 3918376
    [Abstract] [Full Text] [Related]

  • 28. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
    Merrin C, Etra W, Wajsman Z, Baumgartner G, Murphy G.
    J Urol; 1976 Jan; 115(1):86-8. PubMed ID: 1107604
    [Abstract] [Full Text] [Related]

  • 29. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH, Light BW, Lapco PE, Konety BR, Nangia AK, Acierno JS, Dhir R, Shurin Z, Day RS, Trump DL, Johnson CS.
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [Abstract] [Full Text] [Related]

  • 30. Model systems for studies of prostatic cancer.
    Sandberg AA, Gaunt R.
    Semin Oncol; 1976 Jun; 3(2):177-87. PubMed ID: 180612
    [No Abstract] [Full Text] [Related]

  • 31. Cell kinetic studies of prostatic cancer: adjuvant therapy in animal models.
    Weissman RM, Coffey DS, Scott WW.
    Oncology; 1977 Jun; 34(3):133-7. PubMed ID: 917443
    [Abstract] [Full Text] [Related]

  • 32. The Dunning R3327 prostate adenocarcinoma in the Fischer-Copenhagen F1 rat: a useful model for immunological studies.
    Claflin AJ, McKinney EC, Fletcher MA.
    Oncology; 1977 Jun; 34(3):105-9. PubMed ID: 917439
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
    Drago JR, Goldman L, Gershwin ME.
    Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
    [Abstract] [Full Text] [Related]

  • 34. Antitumoral effects of R 75251 on the growth of transplantable R3327 prostatic adenocarcinoma in rats.
    Van Ginckel R, De Coster R, Wouters W, Vanherck W, van der Veer R, Goeminne N, Jagers E, Van Cauteren H, Wouters L, Distelmans W.
    Prostate; 1990 Jul; 16(4):313-23. PubMed ID: 2371176
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of the R3327MAT-Lu prostatic tumor by diethylstilbestrol and 1,2-bis(3,5-dioxopiperazin-1-yl)propane.
    Lazan DW, Heston WD, Kadmon D, Fair WR.
    Cancer Res; 1982 Apr; 42(4):1390-4. PubMed ID: 7060012
    [Abstract] [Full Text] [Related]

  • 36. Dunning R3327-G prostate carcinoma of the rat: an appropriate model for drug evaluation.
    Kager M, Spruss T, Schneider MR, von Angerer E.
    J Cancer Res Clin Oncol; 1992 Apr; 118(5):334-8. PubMed ID: 1583064
    [Abstract] [Full Text] [Related]

  • 37. Oral cyclophosphamide and oral hydroxyurea in the treatment of hormone refractory prostate cancer in rats.
    Naik H, Lehr J, Akhtar A, Pienta K.
    Anticancer Res; 1994 Apr; 14(6B):2681-4. PubMed ID: 7872701
    [Abstract] [Full Text] [Related]

  • 38. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
    Johansson A, Jones J, Pietras K, Kilter S, Skytt A, Rudolfsson SH, Bergh A.
    Prostate; 2007 Nov 01; 67(15):1664-76. PubMed ID: 17854058
    [Abstract] [Full Text] [Related]

  • 39. Combined therapeutic effects of conventional agents and an immunomodulator, PSK, on rat prostatic adenocarcinoma.
    Mickey DD, Carvalho L, Foulkes K.
    J Urol; 1989 Dec 01; 142(6):1594-8. PubMed ID: 2585643
    [Abstract] [Full Text] [Related]

  • 40. The chemotherapy of prostatic carcinoma.
    Beckley S, Wajsman Z, Slack N, Mittelman A, Murphy GP.
    Scand J Urol Nephrol Suppl; 1980 Dec 01; 55():151-62. PubMed ID: 6938019
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.